220 related articles for article (PubMed ID: 18632125)
1. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
2. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
3. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
Cantey PT; Rao G; Rout J; Fox LM
Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
[TBL] [Abstract][Full Text] [Related]
5. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
[TBL] [Abstract][Full Text] [Related]
6. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
[TBL] [Abstract][Full Text] [Related]
7. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
Babu BV
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640
[TBL] [Abstract][Full Text] [Related]
8. Study on the factors affecting the MDA programme in Kerala state.
Showkath Ali MK; Rajendran R; Regu K; Mohanan MK; Dhariwal AC; Lal S
J Commun Dis; 2007 Mar; 39(1):51-6. PubMed ID: 18338717
[TBL] [Abstract][Full Text] [Related]
9. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
[TBL] [Abstract][Full Text] [Related]
10. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Lahariya C; Mishra A
J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
[TBL] [Abstract][Full Text] [Related]
11. Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.
Kerketta AS; Babu BV; Swain BK
Acta Trop; 2007 Jun; 102(3):159-64. PubMed ID: 17553441
[TBL] [Abstract][Full Text] [Related]
12. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
13. Mass drug administration to eliminate lymphatic filariasis in India.
Ramaiah KD; Das PK
Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
[TBL] [Abstract][Full Text] [Related]
14. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
[TBL] [Abstract][Full Text] [Related]
15. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
Babu BV; Satyanarayana K
Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
[TBL] [Abstract][Full Text] [Related]
16. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.
Karmakar PR; Mitra K; Chatterjee A; Jana PK; Bhattacharya S; Lahiri SK
J Vector Borne Dis; 2011 Jun; 48(2):101-4. PubMed ID: 21715733
[No Abstract] [Full Text] [Related]
17. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
[TBL] [Abstract][Full Text] [Related]
18. The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia.
Krentel A; Wellings K
Parasit Vectors; 2018 Mar; 11(1):179. PubMed ID: 29530082
[TBL] [Abstract][Full Text] [Related]
19. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
[TBL] [Abstract][Full Text] [Related]
20. Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.
Babu BV; Behera DK; Kerketta AS; Mishra S; Rath K; Swain BK; Mishra S; Kar SK
Ann Trop Med Parasitol; 2006 Oct; 100(7):621-30. PubMed ID: 16989688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]